Can organophosphate exposure cause acetylcholine accumulation and neurologic symptoms?

Organophosphate exposure is clinically important because these compounds can produce rapid, potentially life-threatening cholinergic toxicity. The central biochemical mechanism in the claim is well established; the attribution of a broad, nonspecific neurologic symptom cluster is more conditional.

Mechanism and clinical toxicity

• Organophosphates covalently inhibit acetylcholinesterase, preventing acetylcholine hydrolysis. Acetylcholine consequently persists at muscarinic, nicotinic, and central cholinergic synapses, causing sustained receptor stimulation and the characteristic cholinergic syndrome.
• In severe acute toxicity, this excess cholinergic signaling can cause respiratory compromise. Acute neurologic manifestations can include dizziness, confusion, and drowsiness; insomnia and memory or other cognitive symptoms have also been reported.
• Red-cell acetylcholinesterase activity may fall within hours, sometimes reaching a nadir at approximately 12–24 hours. It more closely reflects synaptic acetylcholinesterase activity and poisoning severity than plasma butyrylcholinesterase, although treatment of suspected poisoning should not await laboratory results.

Neurologic symptoms: interpretation

• Acetylcholine accumulation is a plausible explanation for dizziness and central cognitive or sleep-related symptoms during a temporally compatible acute cholinergic illness.
• It is less firmly established that this mechanism explains the entire combination of dizziness, sleep disturbance, and cognitive symptoms after chronic or low-level exposure. Observational evidence in older adults has linked estimated organophosphate exposure with faster cognitive decline, while meta-analytic evidence suggests a small, mixed association between low-level exposure and poorer cognition.
• These symptoms are nonspecific, particularly at age 74, and may also reflect medications, vestibular disease, sleep disorders, depression, comorbidity, or other neurologic conditions.

Bottom line

• Organophosphate-mediated acetylcholinesterase inhibition and acetylcholine accumulation are established. Acute cholinergic toxicity can plausibly cause dizziness and central neurologic symptoms, but chronic or low-level exposure should not be assumed to explain sleep or cognitive symptoms without compatible exposure history and objective clinical assessment.